Breaking News Bar

Business News and Information

UPDATE 1-Roche clears UK hurdle in $4.3 bln Spark deal, U.S. review drags on

Swiss drugmaker Roche won clearance from Britain's Competition and Markets Authority (CMA) on Monday for its planned $4.3 billion takeover of gene therapy company Spark Therapeutics, while a similar U.S. review continues.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear